Cargando…
Salvage Therapy for Alveolar Echinococcosis—A Case Series
Benzimidazoles are the only approved drugs for the treatment of inoperable human alveolar echinococcosis but may be limited due to intolerance or, rarely, ineffectiveness. A medical second-line or salvage therapy is not available, though it is urgently needed. We report long-term follow-up data from...
Autores principales: | Burkert, Sanne, Peters, Lynn, Bloehdorn, Johannes, Grüner, Beate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949663/ https://www.ncbi.nlm.nih.gov/pubmed/35335657 http://dx.doi.org/10.3390/pathogens11030333 |
Ejemplares similares
-
Initial Risk Assessment in Patients with Alveolar Echinococcosis—Results from a Retrospective Cohort Study
por: Peters, Lynn, et al.
Publicado: (2022) -
Echinococcus multilocularis specific antibody, systemic cytokine, and chemokine levels, as well as antigen-specific cellular responses in patients with progressive, stable, and cured alveolar echinococcosis: A 10-year follow-up
por: Grüner, Beate, et al.
Publicado: (2022) -
18F-FDG-PET/MR in Alveolar Echinococcosis: Multiparametric Imaging in a Real-World Setting
por: Eberhardt, Nina, et al.
Publicado: (2022) -
(18)FDG-PET/CT-Scans and Biomarker Levels Predicting Clinical Outcome in Patients with Alveolar Echinococcosis—A Single-Center Cohort Study with 179 Patients
por: Peters, Lynn, et al.
Publicado: (2023) -
Experienced stigma and applied coping strategies during the COVID-19 pandemic in Germany: a mixed-methods study
por: Peters, Lynn, et al.
Publicado: (2022)